CA2153570A1 - Composition pharmaceutique permettant de traiter la dependance a la nicotine - Google Patents

Composition pharmaceutique permettant de traiter la dependance a la nicotine

Info

Publication number
CA2153570A1
CA2153570A1 CA002153570A CA2153570A CA2153570A1 CA 2153570 A1 CA2153570 A1 CA 2153570A1 CA 002153570 A CA002153570 A CA 002153570A CA 2153570 A CA2153570 A CA 2153570A CA 2153570 A1 CA2153570 A1 CA 2153570A1
Authority
CA
Canada
Prior art keywords
nicotine dependence
pharmaceutical composition
treating nicotine
treating
galanthamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002153570A
Other languages
English (en)
Other versions
CA2153570C (fr
Inventor
Joachim Arnold Moormann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
HF Arzneimittelforschung GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4301782A external-priority patent/DE4301782C1/de
Application filed by Individual filed Critical Individual
Publication of CA2153570A1 publication Critical patent/CA2153570A1/fr
Application granted granted Critical
Publication of CA2153570C publication Critical patent/CA2153570C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002153570A 1993-01-23 1994-01-10 Composition pharmaceutique permettant de traiter la dependance a la nicotine Expired - Fee Related CA2153570C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4301782.7 1993-01-23
DE4301782A DE4301782C1 (de) 1993-01-23 1993-01-23 Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
PCT/EP1994/000055 WO1994016708A1 (fr) 1993-01-23 1994-01-10 Formulation pharmaceutique pour le traitement de la dependance a l'egard de la nicotine

Publications (2)

Publication Number Publication Date
CA2153570A1 true CA2153570A1 (fr) 1994-08-04
CA2153570C CA2153570C (fr) 2006-12-12

Family

ID=37560896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002153570A Expired - Fee Related CA2153570C (fr) 1993-01-23 1994-01-10 Composition pharmaceutique permettant de traiter la dependance a la nicotine

Country Status (1)

Country Link
CA (1) CA2153570C (fr)

Also Published As

Publication number Publication date
CA2153570C (fr) 2006-12-12

Similar Documents

Publication Publication Date Title
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
CA2239174A1 (fr) Nouveaux composes a effet analgesique
CA2004239A1 (fr) Utilisation de l'acetyl-d-carnitine dans le traitement therapeutique du glaucome et composes pharmaceutiques utiles dans un tel traitement
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
CA2289717A1 (fr) Nouveau traitement de la constipation
CA2274074A1 (fr) Nouveaux composes a effet analgesique
CA2129995A1 (fr) Derives thiacycliques de piperidinyle
CA2258920A1 (fr) Acide hyaluronique autoreticule et compositions pharmaceutiques associees pour le traitement des arthropathies
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
CA2125662A1 (fr) Systeme a administration transdermique contenant de l'acide acetylsalicylique pour le traitement de la thrombose et la prophylaxie du cancer
CA2202397A1 (fr) Compositions comprenant de l'acide dichloroacetique tamponne au carbonate/bicarbonate et procedes de traitement de troubles metaboliques et cardiovasculaires
CA2139385A1 (fr) Produits renfermant une proteine liante de g-csf et de tnf
CA2135614A1 (fr) Utilisation de l'urodilatine pour les affections pulmonaires et bronchiques
WO1999061010A3 (fr) TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
IE881410L (en) Anticoccidial composition
CA2108330A1 (fr) Stimulateur de l'effet anti-anemique de l'erythropoietine et methode d'augmentation de cet effet
EP0362847A3 (fr) Emploi de l'étopéritone pour obtenir une composition pharmaceutique pour le traitement de l'impotence chez l'homme
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
CA2120001A1 (fr) Composition pharmaceutique a base de flavopereirine et son utilisation contre le vih
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
EP0378413A3 (fr) Compositions pour le traitement topique de maladies cutanées
CA2153570A1 (fr) Composition pharmaceutique permettant de traiter la dependance a la nicotine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130110